How location and cellular signaling combine to activate the NLRP3 inflammasome

A Akbal, A Dernst, M Lovotti, MSJ Mangan… - Cellular & molecular …, 2022 - nature.com
Abstract NOD-, LRR-, and pyrin domain-containing 3 (NLRP3) is a cytosolic innate immune
sensor of cellular stress signals, triggered by infection and sterile inflammation. Upon …

Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination

M Zirngibl, P Assinck, A Sizov, AV Caprariello… - Molecular …, 2022 - Springer
Background The dietary consumption of cuprizone–a copper chelator–has long been known
to induce demyelination of specific brain structures and is widely used as model of multiple …

[HTML][HTML] Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy

L Wang, J Cai, X Zhao, L Ma, P Zeng, L Zhou, Y Liu… - Molecular cell, 2023 - cell.com
As a key component of the inflammasome, NLRP3 is a critical intracellular danger sensor
emerging as an important clinical target in inflammatory diseases. However, little is known …

MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition

RC Coll, JR Hill, CJ Day, A Zamoshnikova… - Nature chemical …, 2019 - nature.com
Inhibition of the NLRP3 inflammasome is a promising strategy for the development of new
treatments for inflammatory diseases. MCC950 is a potent and specific small-molecule …

Targeting the NLRP3 inflammasome in inflammatory diseases

MSJ Mangan, EJ Olhava, WR Roush… - Nature reviews Drug …, 2018 - nature.com
Danger signals are a hallmark of many common inflammatory diseases, and these stimuli
can function to activate the cytosolic innate immune signalling receptor NLRP3 (NOD-, LRR …

NLRP3 inflammasome and the IL-1 pathway in atherosclerosis

A Grebe, F Hoss, E Latz - Circulation research, 2018 - Am Heart Assoc
Inflammation is an important driver of atherosclerosis, the underlying pathology of
cardiovascular diseases. Therefore, therapeutic targeting of inflammatory pathways is …

Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity

H He, H Jiang, Y Chen, J Ye, A Wang, C Wang… - Nature …, 2018 - nature.com
Oridonin (Ori) is the major active ingredient of the traditional Chinese medicinal herb
Rabdosia rubescens and has anti-inflammatory activity, but the target of Ori remains …

Mitochondrial damage activates the NLRP10 inflammasome

T Próchnicki, MB Vasconcelos, KS Robinson… - Nature …, 2023 - nature.com
Upon detecting pathogens or cell stress, several NOD-like receptors (NLRs) form
inflammasome complexes with the adapter ASC and caspase-1, inducing gasdermin D …

4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects

ST Liao, C Han, DQ Xu, XW Fu, JS Wang… - Nature …, 2019 - nature.com
Activated macrophages switch from oxidative phosphorylation to aerobic glycolysis, similar
to the Warburg effect, presenting a potential therapeutic target in inflammatory disease. The …

Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders

H Jiang, H He, Y Chen, W Huang, J Cheng… - Journal of Experimental …, 2017 - rupress.org
The NLRP3 inflammasome has been implicated in the pathogenesis of a wide variety of
human diseases. A few compounds have been developed to inhibit NLRP3 inflammasome …